Authors' Reports

Hui-Ling Yeh
describes for SIIC the most significant aspects of his article
describe para SIIC los aspectos relevantes de su artículo

The role of postoperative chemoradiotherapy in the local control and overall survival of locally advanced esophageal squamous cell carcinoma

Our study presented a relatively good local control of the disease by the addition of postoperative chemoradiotherapy to locally advanced esophageal squamous cell carcinoma with a mild, acute treatment-related toxicity, but this did not contribute a higher survival rate for this group of patients.

The article was published by
El artículo fue publicado por
Formosan Journal of Surgery
Volume / Volumen: 45
Number / Número: 6
First and last pages / Páginas inicial-final: 172-177
Year / Año: 2012
Month / Mes: december

This journal, which is covered by SIIC Data Bases,
is part of the bibliographic collections of the Biblioteca Biomédica (BB) SIIC.
Esta revista, clasificada por SIIC Data Bases,
integra el acervo bibliográfico de la Biblioteca Biomédica (BB) SIIC.

Principal institution where the research took place
Institución principal de la investigación
Taichung Veterans General Hospital, Taichung City, Taichung, Taiwan

Authors' Report

Crónica del Autor

Bibliographic references
Referencias bibliográficas

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 60:277-300, 2010.
2. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305-313, 2001.
3. Xiao ZF, Yang ZY, Liang J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 75:331-336, 2003.
4. Yeh HL, Hsu CP, Lin JC, et al. Clinical outcome of postoperative intensity-modulated radiotherapy for esophageal cancer. Therapeut Radiol Oncol 15:269-278, 2008.
5. Rice TW, Adelstein DJ, Chidel MA, et al. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 126:1590-1596, 2003.
6. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730, 2001.
7. AJCC Cancer Staging Manual. 7th ed. 2009.
8. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346, 1995.
9. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323-329, 1999.
10. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (Radiation Therapy Oncology group, RTOG 85-01). JAMA 281:1623-1627, 1999.
11. Tachibana M, Yoshimura H, Kinugasa S, et al. Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. Euro J Surg Oncol 29:580-587, 2003.
12. Adelstein DJ, Rice TW, Rybicki LA, et al. A Phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity. Am J Clin Oncol 30:172-180, 2007.
13. Hofstetter W, Swisher SG, Correa AM, et al. Treatment outcomes of resected esophageal cancer. Ann Surg 236:376-385, 2002.
14. Hsu CP, Chen CY, Hsia JY, Shai SE. Prediction of prognosis by the extent of lymph node involvement in squamous cell carcinoma of thoracic esophagus. Eur J Cardiothorac Surg 19:10-13, 2001.
15. Kofoed SC, Muhic A, Baeksgaard L, et al. Survival after adjuvant chemoradiotherapy or Surgery alone in resectable adenocarcinoma at the gastro-esophageal junction. Scand J Surg 101:26-31, 2012.
16. Adelstein DJ, Rice TW, Rybicki LA, et al. Mature results from a phase ii trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction. J Thorac Oncol 4:1264-1269, 2009.

Other articles written by the author Hui-Ling Yeh
Otros artículos de Hui-Ling Yeh

SIIC System of Assisted Editing (SSEA)
/ Sistema SIIC de Edición Asistida (SSEA)

Hui-Ling Yeh was invited by SIIC on
Hui-Ling Yeh fue invitado por SIIC el
2013, december 19
  The authors' report was accepted on
La crónica del autor fue aprobada el
2023, may 12
The authors' report was accepted on
La crónica del autor fue aprobada el
2023, may 12
Published in siicsalud
Publicado en siicsalud
2023, august 10

The article is strictly related to the following sections of siicsalud
El artículo se relaciona estrictamente con las siguientes secciones de siicsalud

/ Gastroenterología
/ Oncología

and secondarily related to the following sections

y secundariamente con las siguientes secciones


Medical Education
Educación Médica


Family Medicine
Medicina Familiar

Information about the full text
Acerca del trabajo completo

A Retrospective Study of Postoperative Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Author / Autor
Hui-Ling Yeh1

1 Dr., Department Of Radiation Oncology, Taichung Veterans General Hospital, Taichung City, Taiwán (Republica Nacionalista China), Attending Physcian

Access to the original source
Formosan Journal of Surgery

Article URL:
/ URL del artículo:

URL of Abstract:
/ URL del abstract:

URL of Abstract page in Medline:
/ URL del abstract en Medline:

URL of Abstract page in Scielo:
/ URL del abstract en Scielo:

URL of Abstract page in Scopus:
/ URL del abstract en Scopus:

URL of Abstract page in Embase:
/ URL del abstract en Embase:

Other data bases:
/ Otras bases de datos:

siic DB:
/ siic DB: